Xenon Pharmaceuticals Inc. share price logo

Xenon Pharmaceuticals Inc.

NASDAQ: XENE

Mid Cap

$59.74

+2.96

(+5.21%)

as on

Xenon Pharmaceuticals Inc. Stock Performance

as on June 27, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $57.07
    $60.29
    downward going graph

    4.47%

    Downside

    0.92%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $30.00
    $63.95
    downward going graph

    49.78%

    Downside

    7.05%

    Upside

    downward going graph

Xenon Pharmaceuticals Inc. share price movements today

Previous Close
$56.78
Open
$57.38
Volume
2.8M
Day's Low - High
$57.07 - $60.29
52 Week Low - High
$30.00 - $63.95

Xenon Pharmaceuticals Inc. Historical Returns

1 Month Return
+ 5.19 %
3 Month Return
+ 2.25 %
1 Year Return
+ 76.34 %
3 Year Return
+ 45.48 %
5 Year Return
+ 205.43 %

Xenon Pharmaceuticals Inc. Stock Fundamentals & Key Indicators

Check Xenon Pharmaceuticals Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$5.4B

EPS (TTM)

-4.8103

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

-0.06

EBITDA

-410.2M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-37.53%

Xenon Pharmaceuticals Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Xenon Pharmaceuticals Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Xenon Pharmaceuticals Inc. image
Xenon Pharmaceuticals Inc.
BUY$5.4B205.43%NA0.00%NA
Alnylam Pharmaceuticals Inc. image
Alnylam Pharmaceuticals Inc.
BUY$39.3B67.15%74.0712.55%NA
Vertex Pharmaceuticals Inc. image
Vertex Pharmaceuticals Inc.
BUY$120.6B147.08%28.1735.51%NA
Regeneron Pharmaceuticals Inc. image
Regeneron Pharmaceuticals Inc.
BUY$65.4B12.64%15.2229.65%0.58%

Stock Returns calculator for Xenon Pharmaceuticals Inc. Stock including INR - Dollar returns

The Xenon Pharmaceuticals Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Xenon Pharmaceuticals Inc. investment value today

Current value as on today

₹2,04,146

Returns

₹1,04,146

(+104.15%)

Returns from Xenon Pharmaceuticals Inc. Stock

₹85,528 (+85.53%)

Dollar Impact

₹18,618 (+18.62%)

Analyst Recommendation on Xenon Pharmaceuticals Inc. Stock

Based on 24 analysts

BUY

95.83%

Buy

4.17%

Hold

0.00%

Sell

Based on 24 analysts, 95.83% of analysts recommend a 'BUY' rating for Xenon Pharmaceuticals Inc.. Average target price of $80.56

Xenon Pharmaceuticals Inc. Share Price Target

Get share price movements and forecasts by analysts on Xenon Pharmaceuticals Inc..

What analysts predicted

25.84%UPSIDE

Target Price

$80.56

Current Price

$59.74

Analyzed by

24 Analysts

Target

$80.56

Xenon Pharmaceuticals Inc. target price $80.56, a slight upside of 25.84% compared to current price of $59.74. According to 24 analysts rating.

Xenon Pharmaceuticals Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
5
-
-
-
2
7
-
-
-
-
Gross Profit
4
0
0
0
1
7
0
-77
0
0
Operating Income
-53
-59
-69
-73
-77
-72
-94
-96
-109
-112
EBITDA
-52
-58
-68
-72
-76
-72
-93
-89
-104
-111
Interest Expense
7
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-44
-47
-58
-63
-69
-64
-85
-90
-104
-104
Income Tax Expense
0
0
0
0
-3
0
0
0
0
-2
Net Income
-44
-47
-57
-62
-65
-65
-84
-90
-105
-102
Net Profit Margin
-831.65%
0.00%
0.00%
0.00%
-2610.69%
-867.29%
0.00%
0.00%
0.00%
0.00%

Xenon Pharmaceuticals Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
1
0
-
6
32
18
9
-
-
7
Gross Profit
0
-25
-6
6
32
18
9
-167
-2
4
Operating Income
-24
-32
-38
-42
-31
-78
-129
-214
-279
-373
EBITDA
-23
-30
-32
-39
-30
-78
-127
-210
-235
-342
Interest Expense
-
-
1
1
0
1
5
-
-
-
Depreciation
-
0
0
0
0
0
1
3
2
2
Income Before Tax
-22
-30
-34
-41
-29
-78
-125
-182
-238
-344
Income Tax Expense
-1
-1
4
0
0
0
0
0
-4
1
Net Income
-22
-30
-34
-41
-28
-78
-125
-182
-234
-345
Net Profit Margin
-1275.49%
-9872.67%
0.00%
-609.09%
-89.65%
-427.85%
-1328.95%
0.00%
0.00%
-4612.13%

Xenon Pharmaceuticals Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-47
-57
-62
-65
-65
-84
-90
-105
-102
Operating Cash Flow
-46
-32
-49
-54
-61
-64
-71
-81
-88
Investing Cash Flow
-43
110
0
98
34
82
38
62
-407
Financing Cash Flow
-
-
-
12
1
0
2
113
843
Change in Cash
-89
77
-49
55
-26
18
-30
94
346

Xenon Pharmaceuticals Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-30
-34
-41
-28
-78
-125
-182
-234
-345
Operating Cash Flow
-28
-34
-4
-48
-69
-98
-145
-181
-279
Investing Cash Flow
24
-28
-66
-16
-246
-296
-117
165
217
Financing Cash Flow
7
111
27
85
447
278
353
12
117
Change in Cash
3
47
-42
20
130
-118
91
-5
56

Global Institutional Holdings in Xenon Pharmaceuticals Inc.

Funds
Holdings
Adage Capital Partners Gp LLC
1.67%
FMR Inc
11.19%
venBio Select Advisor LLC
5.98%
Geode Capital Management, LLC
0.99%
AllianceBernstein L.P.
1.45%
See all

Xenon Pharmaceuticals Inc. News & Key Events

  • img

    Today's Timeline - 10 March

    Tue, 04:30 PM

    -

    Xenon Pharmaceuticals reports successful late-stage trial results for azetukalner, reducing seizure frequency significantly compared to placebo.

    Wed, 08:11 AM

    -

    Xenon Pharmaceuticals announces pricing of $650 million public offering of common shares and pre-funded warrants.

Insights on Xenon Pharmaceuticals Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, XENE stock has moved up by 12.9%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, XENE has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 2.51M → 7.5M (in $), with an average increase of 66.5% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -105.26M → -102.30M (in $), with an average increase of 2.9% per quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, XENE has outperformed top 5 stocks with highest market-cap in its industry

About Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, engages in the discovery, development, and delivery of therapeutics to treat patients with neurological and psychiatric disorders. Its product candidates include Azetukalner, a novel, potent Kv7 potassium channel opener which is in Phase 3 clinical development for the treatment of epilepsy, including focal onset seizures, and primary generalized tonic-clonic seizures, as well as neuropsychiatric disorders, such as major depressive disorder and bipolar depression. In addition, the company's Phase 1 Single Ascending Dose/Multiple Ascending Dose products include XEN1701 targeting the sodium channel and XEN1120 targeting the Kv7 potassium channel for the treatment of pain. The company has a license and collaboration agreement with Neurocrine Biosciences, Inc. for the development of NBI-921355, a Nav1.2/1.6 sodium channel inhibitor that is in Phase 1 clinical trials for the treatment of certain types of epilepsy. Xenon Pharmaceuticals Inc. was incorporated in 1996 and is headquartered in Burnaby, Canada.
OrganisationXenon Pharmaceuticals Inc.
Headquarters200-3650 Gilmore Way, Burnaby, BC, Canada, V5G 4W8
IndustryBiotechnology
CEOMr. Ian C. Mortimer C.M.A., CPA, M.B.A.
E-voting on sharesClick here to vote

Key Management of Xenon Pharmaceuticals Inc.

Name

Title

Mr. Thomas Patrick Kelly J.D.

Chief Financial Officer

Mr. Darren S. Cline M.B.A.

Chief Commercial Officer

Dr. Matthew D. Ronsheim Ph.D.

Chief Operating Officer

Ms. Shelley McCloskey B.A.

Executive Vice President of Human Resources

Dr. Robin P. Sherrington Ph.D.

Executive Vice President of Strategy & Innovation

Ms. Colleen Alabiso

Senior Vice President of Corporate Affairs

Mr. Ian C. Mortimer C.M.A., CPA, M.B.A.

President, CEO & Director

Ms. Andrea DiFabio J.D.

Chief Legal Officer & Corporate Secretary

Dr. Christopher John Kenney M.D.

Chief Medical Officer

Dr. James R. Empfield Ph.D.

Executive Vice President of Drug Discovery

FAQs

What is Xenon Pharmaceuticals Inc. share price today?

Xenon Pharmaceuticals Inc. share price today is $59.74 as on at the close of the market. Xenon Pharmaceuticals Inc. share today touched a day high of $60.29 and a low of $57.07.

What is the 52 week high and 52 week low for Xenon Pharmaceuticals Inc. share?

Xenon Pharmaceuticals Inc. share touched a 52 week high of $63.95 on and a 52 week low of $30 on . Xenon Pharmaceuticals Inc. stock price today i.e. is closed at $59.74,which is 6.58% down from its 52 week high and 99.13% up from its 52 week low.

What is Xenon Pharmaceuticals Inc.'s market capitalisation today?

Xenon Pharmaceuticals Inc. market capitalisation is $0.01T as on .

How to invest in Xenon Pharmaceuticals Inc. Stock (XENE) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Xenon Pharmaceuticals Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Xenon Pharmaceuticals Inc. Shares that will get you 0.0251 shares as per Xenon Pharmaceuticals Inc. share price of $59.74 per share as on June 27, 2026 at 8:45 am IST.

What is the minimum amount required to buy Xenon Pharmaceuticals Inc. Stock (XENE) from India?

Indian investors can start investing in Xenon Pharmaceuticals Inc. (XENE) shares with as little as ₹94.3 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹943.00 in Xenon Pharmaceuticals Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Xenon Pharmaceuticals Inc. share’s latest price of $59.74 as on June 27, 2026 at 8:45 am IST, you will get 0.1674 shares of Xenon Pharmaceuticals Inc.. Learn more about fractional shares .

What are the returns that Xenon Pharmaceuticals Inc. has given to Indian investors in the last 5 years?

Xenon Pharmaceuticals Inc. stock has given 205.43% share price returns and 27.1% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?